
Massachusetts has landed squarely in the sights of a congressional Medicaid fraud probe, with a powerful House committee demanding records from Governor Maura Healey and state health officials about how the state polices its massive public insurance program.
The formal request is part of a wave of letters sent to 10 states that the committee says are meant to show how states detect and prevent Medicaid fraud. The March 3 outreach ratchets up federal pressure on state-run programs and puts Massachusetts on the clock to lay out its anti-fraud safeguards.
Republican leaders on the House Committee on Energy and Commerce say they mailed the letters on March 3 to governors and Medicaid agency heads in New York, California, Colorado, Massachusetts, Maine, Nebraska, Oregon, Pennsylvania, Vermont and Washington, requesting records and communications "to ensure program integrity," according to the House Committee on Energy & Commerce. In the committee announcement, Chair Brett Guthrie said the panel will continue to pursue "rampant waste, fraud, and abuse."
What the committee asked for
The letters give states until March 17, 2026 to provide written responses and "all responsive documents" about program-integrity efforts, including audits from Jan. 1, 2021 to the present, provider-screening and revalidation procedures, evidence supporting provider sanctions or disenrollments, and the process for making criminal referrals, according to the committee’s transmission to governors. The full list of questions and document requests is published in the committee letters.
The same package circulated to state capitals singles out several high-risk areas that lawmakers want explained in detail, including applied behavioral analysis for children with autism, non-emergency medical transportation (NEMT) and certain home-and-community-based services, according to the letters.
Why Massachusetts was singled out
The committee materials point to recent enforcement actions involving MassHealth as part of the rationale for taking a closer look. They highlight indictments alleging more than $7.8 million in false claims tied to home-health and laboratory billing, along with other guilty pleas related to personal-care attendant schemes, as described by the Massachusetts Attorney General’s Office.
Those prosecutions are cited directly in the committee documents, which ask Massachusetts officials to spell out what steps the state has taken to detect and deter similar schemes and to provide audits and revalidation records that speak to MassHealth oversight.
Local providers worry about funding and services
Health-center and clinic leaders in Massachusetts have told local reporters they are uneasy about the new round of federal scrutiny and the possibility of sudden grant or payment actions that could destabilize care for vulnerable patients, especially in addiction, mental-health and homeless-services programs. Community health leaders described a chill in some programs after federal grant rule changes and enforcement moves, according to reporting by WBUR.
Those fears are amplified by the sheer size of MassHealth. The program has grown substantially over the past two decades and in recent years has carried a budget of roughly $20 billion, making any hit to funding a big deal for both providers and patients. The Boston Globe has detailed the program’s large fiscal footprint in Massachusetts.
Legal and funding risks ahead
The letters arrive in the middle of a broader federal push that has already sparked showdowns elsewhere. In one prominent example, Minnesota sued the federal government after the Centers for Medicare and Medicaid Services deferred roughly $243 million in Medicaid payments tied to programs the agency flagged as high risk, a dispute tracked by legal reporters. Just Security has been cataloguing related lawsuits and administrative actions.
If federal reviewers say they find "serious concerns" in a state’s responses, potential consequences range from heightened oversight and more audits to payment deferrals or other enforcement steps. State officials warn those kinds of moves could strain budgets and disrupt care for residents who depend on Medicaid services. How Massachusetts answers the committee’s questions will help determine whether the review remains a paper exercise or turns into more aggressive federal action.
The March 17 deadline means records and written responses could arrive with the committee within days; what is in those filings will be an early indicator of how MassHealth officials describe their anti-fraud safeguards and what kind of follow-up the committee might pursue.









